Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates
D. Kerjaschki, H.M. Regele, and I. Moosberger Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates J Am Soc Nephrol 15 2004 603
Lymphatic neoangiogenesis in human renal allografts: Results from sequential protocol biopsies
S. Stuht, W. Gwinner, and I. Franz Lymphatic neoangiogenesis in human renal allografts: results from sequential protocol biopsies Am J Transplant 7 2007 377
Restorative and rejection-associated lymphangiogenesis after renal transplantation: Firend or foe?
D.G. Vass, J. Hughes, and L.P. Marson Restorative and rejection-associated lymphangiogenesis after renal transplantation: firend or foe? Transplantation 88 2009 1237
First year changes of myocardial lymphatic endothelial markers in heart transplant recipients
H.J. Geissler, A. Dashkevich, and U.M. Fischer First year changes of myocardial lymphatic endothelial markers in heart transplant recipients Eur J Cardiothorac Surg 29 2006 767
Lymph angiogenesis after lung transplantation and relation to acute organ rejection in humans
A. Dashkevich, C. Heilmann, and G. Kayser Lymph angiogenesis after lung transplantation and relation to acute organ rejection in humans Ann Thorac Surg 90 2010 406
Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants
D. Kerjaschki, N. Huttary, and I. Raab Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants Nat Med 12 2006 230
Cutting edge: Lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation
T. Dietrich, F. Bock, and D. Yuen Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation J Immunol 184 2010 535
Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts
A.I. Nyknen, H. Sandelin, and R. Krebs Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts Circulation 121 2010 1413